Cerebral Ventriculitis
Cerebral Ventriculitis
Explore linked clinical trials. Standard reference: MESH:M05432393 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)? | Cerebral Ventriculitis, Hemorrhage, Infections, Intracranial Hemorrhages, Neuroinflammatory Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system infectious disorder, cerebrovascular disorder, encephalitis, hydrocephalus, intracerebral hemorrhage, nervous system disorder, subarachnoid hemorrhage, vascular disorder, viral infection of central nervous system | Recruiting | Phase 1 | 2026-08-10 | NCT05001750 | |
| Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex | Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, Cerebral Ventriculitis, Infections, Infectious Ventriculitis, Neuroinflammatory Diseases, bacterial infectious disease, bacterial meningitis, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, meningitis, nervous system disorder, viral infection of central nervous system | Not yet recruiting | Phase 2 | 2026-02-24 | NCT07431307 | |
| Effect of Probiotic and Zinc Supplementations on the Clinical Outcome in Pediatric Patients with Ventriculitis | Cerebral Ventriculitis, Infections, Infectious Ventriculitis, Neuroinflammatory Diseases, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, nervous system disorder, viral infection of central nervous system | Recruiting | Phase 4 | 2025-02-25 | NCT06151392 |